BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $159.40M in the quarter ending September 30, 2025, with 36.14% growth. This brings the company's revenue in the last twelve months to $599.82M, up 45.38% year-over-year. In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M with 36.00% growth.

• Revenue (ttm): $599.82M
• Revenue Growth: +45.38%
• P/S Ratio: 2.58
• Revenue / Employee: $1,034,166
• Employees: 580
• Market Cap: 1.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	450.71M	119.30M	36.00%
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%
Dec 31, 2019	48.84M	28.18M	136.45%
Dec 31, 2018	20.65M	-4.53M	-18.00%
Dec 31, 2017	25.19M	-1.17M	-4.43%
Dec 31, 2016	26.35M	-21.90M	-45.39%
Dec 31, 2015	48.26M	34.65M	254.62%
Dec 31, 2014	13.61M	-3.72M	-21.48%
Dec 31, 2013	17.33M	-8.96M	-34.09%
Dec 31, 2012	26.29M	6.65M	33.85%
Dec 31, 2011	19.64M	-42.74M	-68.51%
Dec 31, 2010	62.38M	-12.21M	-16.37%
Dec 31, 2009	74.59M	18.03M	31.87%
Dec 31, 2008	56.56M	-14.68M	-20.60%
Dec 31, 2007	71.24M	65.03M	1,046.79%
Dec 31, 2006	6.21M	6.06M	3,990.38%
Dec 31, 2005	151.87K	-	-